They need to overhaul the industry and it must start with how the FDA approves new and old drugs. For example, drugs should have hard expiry regardless of paten

They need to overhaul the industry and it must start with how the FDA approves new and old drugs. For example, drugs should have hard expiry regardless of patent claims. No more generic exclusivities. More importantly, scrap biosimilars and make all biologic manufacturers turn over the specific details to produce identical products.